Clinical Trial Update: Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections
• Lung Transplant-related Infections

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Transplantation Infection, Cytomegalovirus Infections | Phase 3 | Status: COMPLETED